Acute Flaccid ParalysisAFP-SUHNCT07775066
Pattern of AFP in Chhidren Admitted at Sohag University Hospital
An observational study of Acute Flaccid Paralysis and AFP, run by Mohamed Aboelhamd Ali at 1 site in Egypt.
Trial summary
This study is observational study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children at Sohag University Hospital. This study will include all children admitted to pediatric emergency and intensive care units with claim or suspicion to have acute falccid… Read more about this study
- Who is it for?
- Ages 1 month to 16 years
- Conditions the study is for
- Acute Flaccid Paralysis, AFP, Gullian Barre Syndrome
- What is being tested?
- Observitional follow-up
- How many people
- 30 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Sep 2026to 1 Sep 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 month to 16 years
- All sexes
- No healthy volunteers
- Child
Study population: Pediatric patients aged from 1 month to 16 years old with acute muscle weakness admitted at Sohag University Hospital, Egypt
Who may be able to join
- All patients admitted to pediatric emergency and intensive care units with claim or suspected to have acute flaccid paralysis aged from 1 month Up to 16 years old
Who cannot join
- Children with flaccid paralysis due to causes other than neurogenic causes. No clear history or clinical picture of definite neurological cause. incomplete clinical data.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Spectrum of Acute Flaccid Paralysis in Children Admitted at Sohag University Hospital
This study is observational study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children at Sohag University Hospital.
This study will include all children admitted to pediatric emergency and intensive care units with claim or suspicion to have acute falccid paralysis
Read the detailed description
This study is a single center, Observational Cross Sectional Hospital Based study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children aged from birth to 18 years old at Sohag University Hospital.
All included children with acute flaccid paralysis will be subjected to:
All routine investigation (complete blood count, C.R.P, blood gases, serum electrolytes, coagulation profile, liver and kidney function test) Imaging when indicated (Brain C.T, Brain and spine MRI, Nerve Conduction Study)
- Being tested
- Observitional follow-up
- Keywords
- acute flaccid paralysis, afp, Transverse myelitis, Gullian Barre Syndrome
- Medical subject headings
- acute flaccid myelitis, Myelitis, Transverse
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Observitional follow-upOther
No expiremental intervention. Data will be collected from routine cinical care, medical records and folow up visits according to standard hospital protocols
| Study group | Role | What they receive |
|---|---|---|
| AFP Patients | Cjildren from birth to 18 years old with acute muscle weakness who are followed at sohag university hospital Receives: Other: Observitional follow-up |
What is being measured
The primary outcome is the main question the study is designed to answer.
Full recovery
Full restoration of muscle strength and function.
Measured: 1 Year
Secondary outcomes (2)
Partial Recovery with Residual Weakness
Persistent muscle weakness despite improvement
Measured: 1 Year
Permanent Paralysis
Irreversible loss of motor function due to destruction of motor neurons or severe nerve injury
Measured: 1 Year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2026
- Study start1 Sep 2026 (estimated)
- Primary completion1 Sep 2027 (estimated)
- Study completion1 Sep 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Acute Flaccid ParalysisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Mohamed Aboelhamd Ali
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Mohamed Aboelhamd Ali, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07775066
- Sponsor's protocol ID
- Soh-Med-26-7-33MS
- Acronym
- AFP-SUH
- Status last verified
- Sep 2026
- First submitted
- 15 Aug 2026
- Last updated
- 11 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual Participants data will not be shared due to patient privacy and data protection policies at Sohag University Hospital
Study at a glance
From the registry record, last updated by the sponsor on 11 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Spectrum of Acute Flaccid Paralysis in Children Admitted at Sohag University Hospital
- ClinicalTrials.gov ID
- NCT07775066
- Acronym / sponsor ID
- AFP-SUH / Soh-Med-26-7-33MS
- Keywords
- acute flaccid paralysis, afp, Transverse myelitis, Gullian Barre Syndrome
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Mohamed Aboelhamd AliUniversity, hospital or other
- Study start
- 1 Sep 2026 (estimated)
- Primary completion
- 1 Sep 2027 (estimated)
- Study completion
- 1 Sep 2027 (estimated)
- First posted
- 20 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is observational study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children at Sohag University Hospital.
This study will include all children admitted to pediatric emergency and intensive care units with claim or suspicion to have acute falccid paralysis
Detailed description
This study is a single center, Observational Cross Sectional Hospital Based study aims to study the Clinical profile, Possible risk factors and Outcome of Acute flaccid paralysis in children aged from birth to 18 years old at Sohag University Hospital.
All included children with acute flaccid paralysis will be subjected to:
All routine investigation (complete blood count, C.R.P, blood gases, serum electrolytes, coagulation profile, liver and kidney function test) Imaging when indicated (Brain C.T, Brain and spine MRI, Nerve Conduction Study)
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| AFP Patients | – | Other: Observitional follow-upCjildren from birth to 18 years old with acute muscle weakness who are followed at sohag university hospital |
Who may qualify
- Ages
- 1 month to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Pediatric patients aged from 1 month to 16 years old with acute muscle weakness admitted at Sohag University Hospital, Egypt
Key inclusion criteria (1 listed)
- All patients admitted to pediatric emergency and intensive care units with claim or suspected to have acute flaccid paralysis aged from 1 month Up to 16 years old
Key exclusion criteria (1 listed)
- Children with flaccid paralysis due to causes other than neurogenic causes. No clear history or clinical picture of definite neurological cause. incomplete clinical data.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Observitional follow-upNo expiremental intervention. Data will be collected from routine cinical care, medical records and folow up visits according to standard hospital protocols | Other | AFP Patients |
Primary outcome
Full recovery
Time frame: 1 Year
Full restoration of muscle strength and function.
2 secondary outcomes
Partial Recovery with Residual Weakness
Time frame: 1 Year
Permanent Paralysis
Time frame: 1 Year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Sep 2026.
- Sohag University Hospital - Department Of PediatricsLink provided by the sponsor.
- Individual participant dataSharing planned: No. Individual Participants data will not be shared due to patient privacy and data protection policies at Sohag University Hospital
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Flaccid Paralysis and AFP, run by Mohamed Aboelhamd Ali at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mohamed Aboelhamd Ali (01069741666, noway00557@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Full recovery (time frame: 1 Year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.